Medications
FDA approves 9 generic versions of nerve pain drug Lyrica
The U.S. Food and Drug Administration has approved the first generic copies of a popular, pricey pill for nerve pain.
Jul 22, 2019
0
0
Fibromyalgia
Diseases, Conditions, Syndromes
Q&A: How is fibromyalgia diagnosed?
Dear Mayo Clinic: Is there a specific test to definitively diagnose fibromyalgia? If not, how do doctors confidently diagnose this disorder?
Jun 13, 2019
0
5
Diseases, Conditions, Syndromes
Are most patients with fibromyalgia misdiagnosed?
Recent studies have suggested that most people who have been diagnosed with fibromyalgia by physicians may not actually have the condition. A new Arthritis Care & Research study found that overall agreement between clinicians' ...
Feb 6, 2019
0
2
Diseases, Conditions, Syndromes
Latest non-invasive medical treatment stimulates neurons to reduce symptoms of fibromyalgia
In a unique double-blind study, the Monash Alfred Psychiatry Research Centre (the Research Centre) is investigating the clinical potential of repetitive Transcranial Magnetic Stimulation (rTMS), a non-invasive treatment that ...
Aug 12, 2015
0
155
Neuroscience
Fibromyalgia and the role of brain connectivity in pain inhibition
The cause of fibromyalgia, a chronic pain syndrome is not known. However, the results of a new study that compares brain activity in individuals with and without fibromyalgia indicate that decreased connectivity between pain-related ...
Oct 1, 2014
0
2
Diseases, Conditions, Syndromes
Young people report worse fibromyalgia than older patients, study shows
It may seem counterintuitive, but young and middle-aged fibromyalgia patients report worse symptoms and poorer quality of life than older patients, a Mayo Clinic study shows. Fibromyalgia most often strikes women. It is characterized ...
Oct 26, 2013
0
0
Other
Pfizer Q1 profit up, but drugmaker cuts outlook
Pfizer Inc.'s first-quarter net income rose 53 percent despite falling sales, mainly because the world's second-largest drugmaker took big charges a year ago. Pfizer's results fell short of Wall Street's expectations, and ...
Apr 30, 2013
0
0
